CCRP Socra Exam Cert Exam Questions With Verified Answers Exam With Questions And Correct Verified Answers/

CCRP Socra Exam Cert Exam
nn nn nn nn nn




Questions With Verified Answers Exam
nn nn nn nn




2025-2026 With Questions And Correct
nn nn nn nn nn nn




Verified Answers/
nn nn

nn
nn

21 nnCFR nnPart nn11 nn- nnCORRECT nnANSWER-Electronic nnRecords; nnElectronic
nnSignatures nn
nn

21 nnCFR nnPart nn11 nnSubpart nnB nn- nnCORRECT nnANSWER-Electronic nnRecords nn
nn

21 nnCFR nnPart nn11 nnSubpart nnC nn- nnCORRECT nnANSWER-Electronic nnSignatures nn
nn

21 nnCFR nnPart nn50 nn- nnCORRECT nnANSWER-Protection nnof nnHuman nnSubjects nn
nn

21 nnCFR nnPart nn50 nnSubpart nnB nn- nnCORRECT nnANSWER-Informed nnConsent
nnof nnHuman nn
nn
Subjects
nn

21 nnCFR nnPart nn50 nnSubpart nnD nn- nnCORRECT nnANSWER-Additional nnSafeguards nnfor
nnChildren nnin nn
nn
Clinical
nnInvestigations
nn

21 nnCFR nnPart nn56 nn- nnCORRECT nnANSWER-Institutional nnReview nnBoard nn
nn

21 nnCFR nnPart nn56 nnSubpart nnB nn- nnCORRECT nnANSWER-Organization nnand
nnPersonnel nn
nn

21 nnCFR nnPart nn56 nnSubpart nnC nn- nnCORRECT nnANSWER-IRB nnFunctions nnand
nnOperations nn
nn

21 nnCFR nnPart nn56 nnSubpart nnD nn- nnCORRECT nnANSWER-IRB nnRecords nnand nnReports
nn
nn

21 nnCFR nnPart nn56 nnSubpart nnE nn- nnCORRECT nnANSWER-Administrative
nnActions nnfor nn
nn
Noncompliance
nn

21 nnCFR nnPart nn312 nn- nnCORRECT nnANSWER-Investigational nnNew nnDrug nnApplication
nn
nn

21 nnCFR nnPart nn312 nnSubpart nnB nn- nnCORRECT nnANSWER-Investigational
nnNew nnDrug nn
nn
Application
nn(IND)
nn

21 nnCFR nnPart nn312 nnSubpart nnC nn- nnCORRECT nnANSWER-Administrative nnActions nn
nn

, 21 nnCFR nnPart nn312 nn Subpart nn D nn- nn CORRECT nn ANSWER-Responsibilities nn of
nnSponsors nnand nn
nn
Investigators
nn

21 nnCFR nnPart nn312 nnSubpart nnE nn- nnCORRECT nnANSWER-Drugs nnIntended nnto
nnTreat nnLife-
nn
Threatening nnand nnSeverely-Debilitating

nnIllnesses
nn

21 nnCFR nnPart nn312 nnSubpart nnF nn- nnCORRECT nnANSWER-Miscellaneous nn
nn

21 nnCFR nnPart nn312 nnSubpart nnI nn- nnCORRECT nnANSWER-Expanded nnAccess nnto
nnInvestigational nn
nn
Drugs nnfor nnTreatment
nnUse
nn

21 nnCFR nnPart nn812 nn- nnCORRECT nnANSWER-Investigational nnDevice nnExemptions nn
nn

21 nnCFR nnPart nn812 nn Subpart nn B nn- nn CORRECT nn ANSWER-Application and
nn

nnAdministrative nn
nn
Action
nn

21 nnCFR nnPart nn812 nnSubpart nnC nn- nnCORRECT nnANSWER-Responsibilities nnof
nnSponsors nn
nn

21 nnCFR nnPart nn812 nnSubpart nnD nn- nnCORRECT nnANSWER-IRB nnReview nnand
nnApproval nn
nn

21 nnCFR nnPart nn812 nnSubpart nnE nn- nnCORRECT nnANSWER-Responsibilities nnof
nnInvestigators nn
nn

21 nnCFR nnPart nn812 nnSubpart nnG nn- nnCORRECT nnANSWER-Records nnand nnReports nn
nn

45 nnCFR nnPart nn46 nn- nnCORRECT nnANSWER-Protection nnof nnHuman nnSubjects nn
nn

45 nnCFR nnPart nn46 nnSubpart nnA nn- nnCORRECT nnANSWER-Basic nnHHS nnPolicy nnfor
nnProtection nnof nn
nn
Human
nnSubjects
nn

45 nnCFR nnPart nn46 nnSubpart nnB nn- nnCORRECT nnANSWER-Additional nnProtections nnfor
nnPregnant nn
nn
Women, nnHuman nnFetuses, nnand nnNeonates nnInvolved nnin
nnResearch
nn

45 nnCFR nnPart nn46 nnSubpart nnC nn- nnCORRECT nnANSWER-Additional nnProtections
nnPertaining nnto nn
nn
Biomedical nnand nnBehavioral nnResearch nnInvolving nnPrisoners nnas
nnSubjects
nn